Expert advice for prescribing cannabis medicines for patients with epilepsy—drawn from the Australian clinical experience

Author:

Lawson John12ORCID,O'Brien Terry3,Graham Myfanwy24,Renaud Elianne24,Jones Dean5,Freeman Jeremy6,Lawn Nicholas,Martin Jennifer H.24ORCID

Affiliation:

1. Sydney Children's Hospital Randwick, Neurology; University of New South Wales ‐ Randwick Campus School of Women and Children's Health Sydney New South Wales Australia

2. Australian Centre for Cannabis Clinical and Research Excellence Australia

3. Central Clinical School Monash University Melbourne Victoria Australia

4. Centre for Drug Repurposing and Medicines Research, Clinical Pharmacology, Hunter Medical Research Institute University of Newcastle Australia

5. University of Technology Sydney New South Wales Australia

6. Murdoch Children's Research Institute; The Royal Children's Hospital Melbourne, Western Australian Adult Epilepsy service in Perth Western Australia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference25 articles.

1. TGA.Medicinal Cannabis Guidance Documents 2020 [updated 29/4/2020]. Available from:https://www.tga.gov.au/node/732373

2. ACRE.NSW Cannabis Medicines Prescribing Guidance 2020 [cited 2021 20/7/21]. Available from:https://www.australiancannabinoidresearch.com.au/resources

3. The costs of epilepsy in Australia

4. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

5. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3